EPA/DHA (Omega 3) Ingredients Market size to exceed $5.7bn by 2026

EPA/DHA (Omega 3) Ingredients Market size is set to surpass USD 5.7 billion by 2026; according to a new research report by Global Market Insights, Inc.

The EPA/DHA market size shall observe significant gains in the forecast period 2019 to 2026 owing to the rising adoption of dietary supplements and rapid consumer spending on healthcare products to promote overall wellness. These products help in maintaining blood pressure, support & regulates blood flow along with improving cholesterol levels and preventing cardiovascular diseases. Rising consumer inclination towards Omega 3 fortified products along with easy availability of chewable, gummies, sachets and confectionary items are expected to escalate EPA/DHA (omega 3) ingredients market growth.


Request Sample Buy NowInquiry Before Buying


Supportive regulations & reduction in healthcare costs to promote functional food application

Dietary habits are the leading causes of death and disability with approximately 7,00,000 deaths yearly. Some of the major diseases include cancers, heart diseases, immune function., neuro health, strokes and obesity. More than 1,000 deaths occur from these diseases in the U.S. on a daily basis.

There are various supportive nutrition claims in the EU promoting intake recommendation along with reducing levels of various types of blood fat named triglycerides. These nutritional claims induce the usage of EPA/DHA products by making consumers aware about the consumption of these products.

Global functional foods segment of EPA/DHA (omega 3) ingredients industry was valued at over USD 160 billion in 2018 owing to rapid consumption for fortifying food additives, rising healthcare costs along with growing trends of self-medication. Walnuts, flaxseed oil, salmon, tuna, marine and other fish oils are major source of omega 3 fatty acids, which are emerging as an important ingredient in functional food.

Browse key industry insights spread across 220 pages with 228 market data tables and 37 figures & charts from the report, “EPA/DHA (Omega 3) Ingredients Market Size By Source (Anchovy/Sardine Oil, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oil, Tuna Oil, Cod Liver Oil, Salmon Oil, Krill Oil, Menhaden Oil), By Application (Dietary supplements, Pharmaceuticals, Functional Foods, Pet & Animal Feed, Infant Formulas), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2026” in detail along with the table of contents:

Increasing demand for healthcare products to escalate North America EPA/DHA (omega 3) ingredients industry size

Rising stress levels and hectic routines leading to lifestyle diseases such as blood pressure, diabetes and obesity is increasing the adoption of dietary supplements. More than 75% of the adults in the U.S. consumed these supplements. Rising healthcare costs is attributed towards advanced medical technology, aging population, rapid increases in insured consumers and improved medical facilities.

EPA and DHA supplements promote weight loss and belly fat along with managing serious consequences of obesity such as maintaining high triglyceride levels, inflammation and insulin resistance. Fish oils improves body composition by increasing metabolism and fat burning potential. These products also suppress appetite leading to consumption of fewer calories which is expected to positively influence industry growth.

American Heart Association recommend consumption of fish and fish oil at least twice a week to reduce heart strokes & risks. Fish oils are most well recognized supplements available in the U.S. and are majorly found in various food products. Food & Drug Administration (FDA), approves highly purified omega 3 FA formulations either containing mixtures of EPA/DHA or EPA alone.

Shifting consumer preferences towards personalized nutrition which refers to individuals creating their own plan and nutritional intake will boost product demand. These supplements are available in consumer-friendly forms including chewable, syrups, gummies and soft gels which further boosts adoption.

Microencapsulation & nanoparticle technology to accelerate the EPA/DHA (omega 3) ingredients market share

Rising application scope in beverages with nano particle emulsion and microencapsulation technology promoting product stability shelf life along with minimizing costs will enhance market demand. The technology also enhances the efficacy and absorption of DHA and further aids in overcoming blood-brain barrier.  

Oceans Omega, which is a fully owned subsidiary of My Cell’s offers aqueous friendly omega 3 solution which delivers both stabilization and solubilization for formulators. The company provides various superior & stable Omega 3 emulsions which are soluble in finished products delivering shelf stable products having no influence on odor, texture or taste.

The companies in the EPA/DHA (omega 3) ingredients market are highly focusing on mergers & acquisitions & new product development. Manufacturers are also involved in developing consumer friendly products for enhancing tastes & convenience.  Major players in the global market includes Croda, Inc., DSM, COPEINICA, Arista Industries, BASF and Clover Corporation.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X